Terns Pharmaceuticals, Inc.
TERNDelisted May 5, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831363
Terns Pharmaceuticals, Inc. was delisted on May 5, 2026; its insiders filed their last Form 4 on May 5, 2026; 317 institutions reported holding it in 13F filings for Q1 2026, worth $6.56B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q1 2022
Institutional positions in Terns Pharmaceuticals, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 44
- +7 vs. Q4 2021
- Shares held
- 16.8M
- +333.1K (+2.0%) vs. Q4 2021
- Total value
- $50.0M
- −$66.7M (−57.1%) vs. Q4 2021
- New holders
- 9
- 10 more added
- Sold out
- 2
- 14 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TERN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $75.4K |
| Q1 2026 | 317 | $6.56B |
| Q4 2025 | 248 | $4.95B |
| Q3 2025 | 141 | $665.7M |
| Q2 2025 | 130 | $310.0M |
| Q1 2025 | 138 | $229.4M |
| Q4 2024 | 157 | $477.2M |
| Q3 2024 | 156 | $663.1M |
| Q2 2024 | 126 | $446.7M |
| Q1 2024 | 112 | $414.8M |
| Q4 2023 | 103 | $412.7M |
| Q3 2023 | 93 | $310.4M |
| Q2 2023 | 103 | $505.0M |
| Q1 2023 | 79 | $630.2M |
| Q4 2022 | 65 | $506.2M |
| Q3 2022 | 45 | $178.1M |
| Q2 2022 | 42 | $36.5M |
| Q1 2022 | 44 | $50.0M |
| Q4 2021 | 37 | $116.7M |
| Q3 2021 | 34 | $174.3M |
| Q2 2021 | 36 | $203.8M |
| Q1 2021 | 42 | $393.7M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Terns Pharmaceuticals, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 3,791,204 | $11.3M | 0.18% | 00.0% | Unchanged |
| Vivo Capital, LLC | 2,675,133 | $7.95M | 0.55% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 2,345,959 | $6.97M | 0.16% | 00.0% | Unchanged |
| FMR LLC | 2,321,458 | $6.89M | 0.00% | −479,527−17.1% | Reduced |
| Suvretta Capital Management, LLC | 1,238,800 | $3.68M | 0.11% | 00.0% | Unchanged |
| Antara Capital LP | 1,074,834 | $3.19M | 0.25% | +125,000+13.2% | Added |
| BlackRock Inc. | 736,941 | $2.19M | 0.00% | −8,594−1.2% | Reduced |
| Decheng Capital Management III (Cayman), LLC | 714,285 | $2.12M | 0.65% | +714,285 | New |
| Vanguard Group Inc | 433,019 | $1.29M | 0.00% | −125,308−22.4% | Reduced |
| Samsara BioCapital, LLC | 289,068 | $859.0K | 0.22% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 179,311 | $532.0K | 0.00% | −1,624−0.9% | Reduced |
| State Street Corp | 163,237 | $485.0K | 0.00% | +1,218+0.8% | Added |
| Point72 Asset Management, L.P. | 122,573 | $364.0K | 0.00% | +122,573 | New |
| Northern Trust Corp | 104,822 | $311.0K | 0.00% | −7,214−6.4% | Reduced |
| Millennium Management LLC | 88,510 | $263.0K | 0.00% | +35,229+66.1% | Added |
| Caas Capital Management LP | 85,851 | $255.0K | 0.04% | 00.0% | Unchanged |
| Cowen and Company, LLC | 85,000 | $252.0K | 0.03% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 67,800 | $201.0K | 0.00% | +67,800 | New |
| Bridgeway Capital Management, LLC | 62,700 | $186.0K | 0.00% | −32,800−34.3% | Reduced |
| Bank of New York Mellon Corp | 38,059 | $112.0K | 0.00% | +2,359+6.6% | Added |
| Driehaus Capital Management LLC | 35,100 | $104.0K | 0.00% | +35,100 | New |
| Charles Schwab Investment Management Inc | 28,746 | $86.0K | 0.00% | 00.0% | Unchanged |
| Marquette Asset Management, LLC | 21,802 | $65.0K | 0.02% | +5,183+31.2% | Added |
| Parametric Portfolio Associates LLC | 20,784 | $62.0K | 0.00% | +8,467+68.7% | Added |
| Goldman Sachs Group Inc | 16,427 | $49.0K | 0.00% | +1,219+8.0% | Added |
| Barclays PLC | 15,352 | $46.0K | 0.00% | +15,352 | New |
| Nuveen Asset Management, LLC | 14,237 | $43.0K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 9,367 | $28.0K | 0.00% | +1,923+25.8% | Added |
| Morgan Stanley | 8,491 | $25.0K | 0.00% | −80,965−90.5% | Reduced |
| Deutsche Bank AG | 8,033 | $24.0K | 0.00% | −878−9.9% | Reduced |
| Bank of America Corp | 7,224 | $21.0K | 0.00% | −1,361−15.9% | Reduced |
| American International Group, Inc. | 6,811 | $20.0K | 0.00% | −478−6.6% | Reduced |
| California State Teachers Retirement System | 5,987 | $18.0K | 0.00% | −2,173−26.6% | Reduced |
| New York State Common Retirement Fund | 5,918 | $18.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 3,556 | $11.0K | 0.00% | +2,013+130.5% | Added |
| Amalgamated Bank | 2,079 | $6.00K | 0.00% | +2,079 | New |
| Amalgamated Financial Corp. | 2,079 | $6.00K | 0.00% | +2,079 | New |
| Legal & General Group Plc | 1,454 | $4.00K | 0.00% | +175+13.7% | Added |
| Cubist Systematic Strategies, LLC | 1,200 | $4.00K | 0.00% | +1,200 | New |
| Citigroup Inc | 1,067 | $3.00K | 0.00% | −3,219−75.1% | Reduced |
| Royal Bank of Canada | 843 | $3.00K | 0.00% | −2,231−72.6% | Reduced |
| Wells Fargo & Company | 613 | $2.00K | 0.00% | −4,866−88.8% | Reduced |
| Ameritas Investment Partners, Inc. | 708 | $2.00K | 0.00% | 00.0% | Unchanged |
| Point72 Hong Kong Ltd | 71 | $0 | 0.00% | +71 | New |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −55,222−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −3,775−100.0% | Sold out |